Thrivent Financial for Lutherans
ARRY

Thrivent Financial for Lutherans’s Array Biopharma Inc ARRY Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-164,153
Closed -$7.61M – 2273
2019
Q2 		$7.61M Buy
+164,153
New +$4.61M 0.02% 591

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Thrivent Financial for Lutherans's ARRY Position: Q3 2019 in Review

Thrivent Financial for Lutherans sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 164,153 shares — an estimated $7.61M sold.

Thrivent Financial for Lutherans first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $7.61M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Thrivent Financial for Lutherans reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 164,153 Array Biopharma Inc shares in Q3 2019, an estimated $7.61M.
  • Thrivent Financial for Lutherans first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's Array Biopharma Inc position peaked at $7.61M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2019, filed 14 Nov 2019.